{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T21:14:43Z","timestamp":1720905283413},"reference-count":64,"publisher":"Portland Press Ltd.","issue":"2","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,4,15]]},"abstract":"<jats:p>Malignant mesothelioma is an asbestos-related cancer that occurs most commonly in the pleural space and is incurable. Increasing evidence suggests that aberrant receptor tyrosine kinase (RTK)-directed signalling plays a key role in the pathogenesis of this cancer. In the majority of mesotheliomas, up-regulated expression or signalling by Met, the receptor for hepatocyte growth factor (HGF) can be demonstrated. Following binding of ligand, Met relays signals that promote cell survival, proliferation, movement, invasiveness, branching morphogenesis and angiogenesis. Here we describe the HGF\/Met axis and review the mechanisms that lead to the aberrant activation of this signalling system in mesothelioma. We also describe the cross-talk that occurs between HGF\/Met and a number of other receptors, ligands and co-receptor systems. The prevalent occurrence of HGF\/Met dysregulation in patients with mesothelioma sets the scene for the investigation of pharmaceutical inhibitors of this axis. In light of the inter-relationship between HGF\/Met and other ligand receptor, combinatorial targeting strategies may provide opportunities for therapeutic advancement in this challenging tumour.<\/jats:p>","DOI":"10.1042\/bst20150252","type":"journal-article","created":{"date-parts":[[2016,4,11]],"date-time":"2016-04-11T09:57:10Z","timestamp":1460368630000},"page":"363-370","update-policy":"http:\/\/dx.doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The role of the HGF\/Met axis in mesothelioma"],"prefix":"10.1042","volume":"44","author":[{"given":"Thivyan","family":"Thayaparan","sequence":"first","affiliation":[{"name":"King's College London, King's Health Partners Integrated Cancer Centre, Department of Research Oncology, Guy's Hospital Campus, Great Maze Pond, London SE1 9RT, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James F.","family":"Spicer","sequence":"additional","affiliation":[{"name":"King's College London, King's Health Partners Integrated Cancer Centre, Department of Research Oncology, Guy's Hospital Campus, Great Maze Pond, London SE1 9RT, U.K."},{"name":"Department of Medical Oncology, Guy's and St Thomas' Hospital, NHS Foundation Trust, Great Maze Pond, London SE1 9RT, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Maher","sequence":"additional","affiliation":[{"name":"King's College London, King's Health Partners Integrated Cancer Centre, Department of Research Oncology, Guy's Hospital Campus, Great Maze Pond, London SE1 9RT, U.K."},{"name":"Department of Immunology, Royal Free NHS Foundation Trust, Barnet Hospital, Hertfordshire EN5 3DJ, U.K."},{"name":"Department of Clinical Immunology and Allergy, King's College Hospital NHS Foundation Trust, Denmark Hill, London SE5 9RS, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"288","published-online":{"date-parts":[[2016,4,11]]},"reference":[{"key":"2021111818073762400_B1","first-page":"491","article-title":"Malignant pleural mesothelioma: an epidemiological perspective","volume":"1","author":"Robinson","year":"2012","journal-title":"Ann. Cardiothorac. Surg."},{"key":"2021111818073762400_B2","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1038\/sj.bjc.6602307","article-title":"The expected burden of mesothelioma mortality in Great Britain from 2002 to","volume":"92","author":"Hodgson","year":"2005","journal-title":"Br. J. Cancer"},{"key":"2021111818073762400_B3","doi-asserted-by":"publisher","first-page":"6881","DOI":"10.1200\/JCO.20005.14.589","article-title":"Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada","volume":"23","author":"van Meerbeeck","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"2021111818073762400_B4","first-page":"S397","article-title":"Malignant pleural mesothelioma: current and future perspectives","volume":"5","author":"Porpodis","year":"2013","journal-title":"J. Thorac. Dis."},{"key":"2021111818073762400_B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1349-7006.2009.01336.x","article-title":"Genomic abnormalities and signal transduction dysregulation in malignant mesothelioma cells","volume":"101","author":"Sekido","year":"2010","journal-title":"Cancer Sci."},{"key":"2021111818073762400_B6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.lungcan.2008.06.011","article-title":"MET as a target for treatment of chest tumors","volume":"63","author":"Cipriani","year":"2009","journal-title":"Lung Cancer"},{"key":"2021111818073762400_B7","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S0962-8924(98)01359-2","article-title":"Developmental roles of HGF\/SF and its receptor, the c-Met tyrosine kinase","volume":"8","author":"Birchmeier","year":"1998","journal-title":"Trends Cell Biol."},{"key":"2021111818073762400_B8","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/376768a0","article-title":"Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud","volume":"376","author":"Bladt","year":"1995","journal-title":"Nature"},{"key":"2021111818073762400_B9","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/373699a0","article-title":"Scatter factor\/hepatocyte growth factor is essential for liver development","volume":"373","author":"Schmidt","year":"1995","journal-title":"Nature"},{"key":"2021111818073762400_B10","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/373702a0","article-title":"Placental defect and embryonic lethality in mice lacking hepatocyte growth factor\/scatter factor","volume":"373","author":"Uehara","year":"1995","journal-title":"Nature"},{"key":"2021111818073762400_B11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/(SICI)1096-9896(199612)180:4&lt;389::AID-PATH685&gt;3.0.CO;2-K","article-title":"Immunoreactivity for hepatocyte growth factor\/scatter factor and its receptor, met, in human lung carcinomas and malignant mesotheliomas","volume":"180","author":"Harvey","year":"1996","journal-title":"J. Pathol."},{"key":"2021111818073762400_B12","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/bjc.1996.64","article-title":"Hepatocyte growth factor\/scatter factor is present in most pleural effusion fluids from cancer patients","volume":"73","author":"Eagles","year":"1996","journal-title":"Br. J. Cancer"},{"key":"2021111818073762400_B13","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s004320050171","article-title":"Hepatocyte growth factor\/scatter factor and its receptor c-Met are overexpressed and associated with an increased microvessel density in malignant pleural mesothelioma","volume":"124","author":"Tolnay","year":"1998","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"2021111818073762400_B14","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1158\/0008-5472.CAN-04-4567","article-title":"Functional analysis of c-Met\/hepatocyte growth factor pathway in malignant pleural mesothelioma","volume":"66","author":"Jagadeeswaran","year":"2006","journal-title":"Cancer Res."},{"key":"2021111818073762400_B15","doi-asserted-by":"publisher","first-page":"8122","DOI":"10.1158\/1078-0432.CCR-05-1191","article-title":"Inhibition of the met receptor in mesothelioma","volume":"11","author":"Mukohara","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"2021111818073762400_B16","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1097\/JTO.0b013e318215a07d","article-title":"Coactivation of receptor tyrosine kinases in malignant mesothelioma as a rationale for combination targeted therapy","volume":"6","author":"Brevet","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"2021111818073762400_B17","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/bjc.1998.176","article-title":"Expression of HGF\/SF in mesothelioma cell lines and its effects on cell motility, proliferation and morphology","volume":"77","author":"Harvey","year":"1998","journal-title":"Br. J. Cancer"},{"key":"2021111818073762400_B18","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/j.ajpath.2011.05.060","article-title":"Pleural mesothelioma instigates tumor-associated fibroblasts to promote progression via a malignant cytokine network","volume":"179","author":"Li","year":"2011","journal-title":"Am. J. Pathol."},{"key":"2021111818073762400_B19","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/(SICI)1097-0215(19980413)76:2&lt;240::AID-IJC12&gt;3.0.CO;2-G","article-title":"Hepatocyte growth factor\/scatter factor stimulates chemotaxis and growth of malignant mesothelioma cells through c-met receptor","volume":"76","author":"Klominek","year":"1998","journal-title":"Int. J. Cancer"},{"key":"2021111818073762400_B20","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/carcin\/bgp097","article-title":"Combined inhibition of MET and EGFR suppresses proliferation of malignant mesothelioma cells","volume":"30","author":"Kawaguchi","year":"2009","journal-title":"Carcinogenesis"},{"key":"2021111818073762400_B21","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/JTO.0b013e3182417da5","article-title":"Plasma cell membrane localization of c-MET predicts longer survival in patients with malignant mesothelioma: a series of 157 cases from the MESOPATH Group","volume":"7","author":"Levallet","year":"2012","journal-title":"J. Thorac. Oncol."},{"key":"2021111818073762400_B22","first-page":"3539","article-title":"Microarray analysis and RNA silencing link fra-1 to cd44 and c-met expression in mesothelioma","volume":"63","author":"Ramos-Nino","year":"2003","journal-title":"Cancer Res."},{"key":"2021111818073762400_B23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nrc3205","article-title":"Targeting MET in cancer: rationale and progress","volume":"12","author":"Gherardi","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"2021111818073762400_B24","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1080\/019021401753181854","article-title":"KGF and HGF are growth factors for mesothelial cells in pleural lavage fluid after intratracheal asbestos","volume":"27","author":"Adamson","year":"2001","journal-title":"Exp. Lung Res."},{"key":"2021111818073762400_B25","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1158\/0008-5472.CAN-13-2062","article-title":"Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR34a-c-Met axis","volume":"74","author":"Menges","year":"2013","journal-title":"Cancer Res."},{"key":"2021111818073762400_B26","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.tcb.2009.07.002","article-title":"Crosstalk in Met receptor oncogenesis","volume":"19","author":"Lai","year":"2009","journal-title":"Trends Cell Biol."},{"key":"2021111818073762400_B27","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/MCP.0b013e3283018220","article-title":"The relationship between simian virus 40 and mesothelioma","volume":"14","author":"Rivera","year":"2008","journal-title":"Curr. Opin. Pulm. Med."},{"key":"2021111818073762400_B28","doi-asserted-by":"publisher","first-page":"12032","DOI":"10.1073\/pnas.211026798","article-title":"SV40 replication in human mesothelial cells induces HGF\/Met receptor activation: a model for viral-related carcinogenesis of human malignant mesothelioma","volume":"98","author":"Cacciotti","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111818073762400_B29","doi-asserted-by":"publisher","first-page":"6080","DOI":"10.1038\/sj.onc.1208744","article-title":"Human and mouse mesotheliomas exhibit elevated AKT\/PKB activity, which can be targeted pharmacologically to inhibit tumor cell growth","volume":"24","author":"Altomare","year":"2005","journal-title":"Oncogene"},{"key":"2021111818073762400_B30","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1054\/bjoc.2000.1445","article-title":"Hepatocyte growth factor\/scatter factor enhances the invasion of mesothelioma cell lines and the expression of matrix metalloproteinases","volume":"83","author":"Harvey","year":"2000","journal-title":"Br. J. Cancer"},{"key":"2021111818073762400_B31","doi-asserted-by":"publisher","first-page":"5152","DOI":"10.1128\/MCB.12.11.5152","article-title":"Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor","volume":"12","author":"Rong","year":"1992","journal-title":"Mol. Cell Biol."},{"key":"2021111818073762400_B32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1126\/science.7505952","article-title":"The Met proto-oncogene mesenchymal to epithelial cell conversion","volume":"263","author":"Tsarfaty","year":"1994","journal-title":"Science"},{"key":"2021111818073762400_B33","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/modpathol.2011.144","article-title":"Epithelial-mesenchymal transition in malignant mesothelioma","volume":"25","author":"Fassina","year":"2012","journal-title":"Mod. Pathol."},{"key":"2021111818073762400_B34","volume-title":"Experimental Cancer Therapeutics Targeting the Hepatocyte Growth Factor\/Met Signaling Pathway","author":"Cecchi"},{"key":"2021111818073762400_B35","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2174\/138920311795659425","article-title":"The HGF-met signaling axis: emerging themes and targets of inhibition","volume":"12","author":"Steffan","year":"2011","journal-title":"Curr. Protein Pept. Sci."},{"key":"2021111818073762400_B36","doi-asserted-by":"publisher","first-page":"22913","DOI":"10.1074\/jbc.273.36.22913","article-title":"Cooperative interaction between alpha- and beta-chains of hepatocyte growth factor on c-Met receptor confers ligand-induced receptor tyrosine phosphorylation and multiple biological responses","volume":"273","author":"Matsumoto","year":"1998","journal-title":"J. Biol. Chem."},{"key":"2021111818073762400_B37","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1002\/ijc.25197","article-title":"Inhibition of Met\/HGF receptor and angiogenesis by NK4 leads to suppression of tumor growth and migration in malignant pleural mesothelioma","volume":"127","author":"Suzuki","year":"2010","journal-title":"Int. J. Cancer"},{"key":"2021111818073762400_B38","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3390\/ijms14010888","article-title":"HGF-MET cascade, a key target for inhibiting cancer metastasis: the impact of NK4 discovery on cancer biology and therapeutics","volume":"14","author":"Mizuno","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"2021111818073762400_B39","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1021\/cb400660a","article-title":"GSK3 alpha and beta are new functionally relevant targets of tivantinib in lung cancer cells","volume":"9","author":"Remsing Rix","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"2021111818073762400_B40","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1038\/jid.2011.414","article-title":"Sema4D, the ligand for Plexin B1, suppresses c-Met activation and migration and promotes melanocyte survival and growth","volume":"132","author":"Soong","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"2021111818073762400_B41","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1159\/000216352","article-title":"CXCR4 and SDF-1 production are stimulated by hepatocyte growth factor and promote glioma cell invasion","volume":"32","author":"Tu","year":"2009","journal-title":"Onkologie"},{"key":"2021111818073762400_B42","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1126\/science.1141478","article-title":"MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling","volume":"316","author":"Engelman","year":"2007","journal-title":"Science"},{"key":"2021111818073762400_B43","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1200\/JCO.2006.09.7634","article-title":"Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study","volume":"25","author":"Garland","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"2021111818073762400_B44","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.ctrv.2010.11.004","article-title":"Targeted epidermal growth factor receptor therapy in malignant pleural mesothelioma: where do we stand?","volume":"37","author":"Agarwal","year":"2011","journal-title":"Cancer Treat. Rev."},{"key":"2021111818073762400_B45","doi-asserted-by":"publisher","first-page":"e36856","DOI":"10.1371\/journal.pone.0036856","article-title":"Perifosine as a potential novel anti-cancer agent inhibits EGFR\/MET-AKT axis in malignant pleural mesothelioma","volume":"7","author":"Pinton","year":"2012","journal-title":"PLoS One"},{"key":"2021111818073762400_B46","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1038\/sj.onc.1203620","article-title":"Cross-talk between the proto-oncogenes Met and Ron","volume":"19","author":"Follenzi","year":"2000","journal-title":"Oncogene"},{"key":"2021111818073762400_B47","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S0169-5002(11)70052-6","article-title":"Expression of the receptor MST1R\/RON and its ligand MSP in malignant pleural mesothelioma","volume":"71","author":"Gray","year":"2011","journal-title":"Lung Cancer"},{"key":"2021111818073762400_B48","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1593\/neo.101156","article-title":"Targeted inhibition of multiple receptor tyrosine kinases in mesothelioma","volume":"13","author":"Ou","year":"2011","journal-title":"Neoplasia"},{"key":"2021111818073762400_B49","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.mce.2013.04.018","article-title":"AXL and MET crosstalk to promote gonadotropin releasing hormone (GnRH) neuronal cell migration and survival","volume":"374","author":"Salian-Mehta","year":"2013","journal-title":"Mol. Cell Endocrinol."},{"key":"2021111818073762400_B50","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1002\/ijc.28169","article-title":"Ligand-independent activation of MET through IGF-1\/IGF-1R signaling","volume":"133","author":"Varkaris","year":"2013","journal-title":"Int. J. Cancer"},{"key":"2021111818073762400_B51","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/JTO.0b013e31828c2b26","article-title":"Phase 2 study of sorafenib in malignant mesothelioma previously treated with platinum-containing chemotherapy","volume":"8","author":"Papa","year":"2013","journal-title":"J. Thorac Oncol."},{"key":"2021111818073762400_B52","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1101\/gad.242602","article-title":"CD44 is required for two consecutive steps in HGF\/c-Met signaling","volume":"16","author":"Orian-Rousseau","year":"2002","journal-title":"Genes Dev."},{"key":"2021111818073762400_B53","doi-asserted-by":"publisher","first-page":"6105","DOI":"10.1158\/0008-5472.CAN-05-0207","article-title":"A five-amino-acid peptide blocks Met- and Ron-dependent cell migration","volume":"65","author":"Matzke","year":"2005","journal-title":"Cancer Res."},{"key":"2021111818073762400_B54","doi-asserted-by":"publisher","first-page":"30643","DOI":"10.1074\/jbc.M702573200","article-title":"CD44 regulates hepatocyte growth factor-mediated vascular integrity. Role of c-Met, Tiam1\/Rac1, dynamin 2, and cortactin.","volume":"282","author":"Singleton","year":"2007","journal-title":"J. Biol. Chem."},{"key":"2021111818073762400_B55","first-page":"196","article-title":"High CD44 expression on human mesotheliomas mediates association with hyaluronan","volume":"1","author":"Penno","year":"1995","journal-title":"Cancer J. Sci. Am."},{"key":"2021111818073762400_B56","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/JTO.0b013e318200f447","article-title":"The use of pleural fluid sCD44v6\/std ratio for distinguishing mesothelioma from other pleural malignancies","volume":"6","author":"Porcel","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"2021111818073762400_B57","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1091\/mbc.E11-02-0134","article-title":"c-Met recruits ICAM-1 as a coreceptor to compensate for the loss of CD44 in Cd44 null mice","volume":"22","author":"Olaku","year":"2011","journal-title":"Mol. Biol. Cell"},{"key":"2021111818073762400_B58","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/(SICI)1096-9896(199607)179:3&lt;266::AID-PATH592&gt;3.0.CO;2-Y","article-title":"Expression of ICAM-1 and VCAM-1 in human malignant mesothelioma","volume":"179","author":"Ruco","year":"1996","journal-title":"J. Pathol."},{"key":"2021111818073762400_B59","doi-asserted-by":"publisher","first-page":"28970","DOI":"10.1074\/jbc.M402508200","article-title":"Reactive oxygen species mediate Met receptor transactivation by G protein-coupled receptors and the epidermal growth factor receptor in human carcinoma cells","volume":"279","author":"Fischer","year":"2004","journal-title":"J. Biol. Chem."},{"key":"2021111818073762400_B60","doi-asserted-by":"publisher","first-page":"8425","DOI":"10.1073\/pnas.93.16.8425","article-title":"Cellular adherence elicits ligand-independent activation of the Met cell-surface receptor","volume":"93","author":"Wang","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111818073762400_B61","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1242\/dev.027805","article-title":"Coordinate integrin and c-Met signaling regulate Wnt gene expression during epithelial morphogenesis","volume":"136","author":"Liu","year":"2009","journal-title":"Development"},{"key":"2021111818073762400_B62","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0092-8674(01)00567-0","article-title":"A signaling adapter function for alpha6beta4 integrin in the control of HGF-dependent invasive growth","volume":"107","author":"Trusolino","year":"2001","journal-title":"Cell"},{"key":"2021111818073762400_B63","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1038\/onc.2013.474","article-title":"Semaphorin receptors meet receptor tyrosine kinases on the way of tumor progression","volume":"33","author":"Cagnoni","year":"2013","journal-title":"Oncogene"},{"key":"2021111818073762400_B64","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/ncb843","article-title":"The semaphorin 4D receptor controls invasive growth by coupling with Met","volume":"4","author":"Giordano","year":"2002","journal-title":"Nat. Cell Biol."}],"container-title":["Biochemical Society Transactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article-pdf\/44\/2\/363\/432206\/bst0440363.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article-pdf\/44\/2\/363\/432206\/bst0440363.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T18:27:59Z","timestamp":1637260079000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article\/44\/2\/363\/67398\/The-role-of-the-HGF-Met-axis-in-mesothelioma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,11]]},"references-count":64,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,4,11]]},"published-print":{"date-parts":[[2016,4,15]]}},"URL":"https:\/\/doi.org\/10.1042\/bst20150252","relation":{},"ISSN":["0300-5127","1470-8752"],"issn-type":[{"value":"0300-5127","type":"print"},{"value":"1470-8752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,11]]}}}